These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3956755)

  • 1. In vitro thymidine labelling index in primary operable breast cancer.
    Holt S; Croton R; Leinster SJ; McDicken I; Nicholson RI; Cooke TG; George WD
    Eur J Surg Oncol; 1986 Mar; 12(1):53-7. PubMed ID: 3956755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy and TLI in association with other prognostic parameters in breast cancer.
    Midulla C; Cenci M; De Iorio P; Pisani T; Bonaccorsi A; De Marchis L; Nofroni I; Vecchione A
    Anticancer Res; 1999; 19(1A):381-4. PubMed ID: 10226571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro DNA synthesis in freshly separated human breast cancer cells assessed by tritiated thymidine incorporation assay: relationship to the long-term outcome of patients.
    Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
    Br J Surg; 1999 Nov; 86(11):1463-9. PubMed ID: 10583297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability and stability of the thymidine labeling index of breast carcinoma.
    Meyer JS; McDivitt RW
    Lab Invest; 1986 Feb; 54(2):160-4. PubMed ID: 3945050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.
    Haffty BG; Hauser A; Choi DH; Parisot N; Rimm D; King B; Carter D
    Cancer; 2004 Jan; 100(2):252-63. PubMed ID: 14716758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.
    Meyer JS
    NCI Monogr; 1986; (1):25-8. PubMed ID: 3774013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.
    Meyer JS; Hixon B
    Cancer Res; 1979 Oct; 39(10):4042-7. PubMed ID: 476641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The labelling index as a prognostic marker in breast carcinoma].
    Bisail M; Nieddu S; Sarobba MG; Sanna G; Milia V; Ghì MG; Farris A
    Minerva Med; 1994 Apr; 85(4):141-4. PubMed ID: 8028740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
    Willner J; Kiricuta IC; Kölbl O
    Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes.
    Moore MP; Kinne DW
    Important Adv Oncol; 1996; ():245-50. PubMed ID: 8791140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
    Kattan MW; Giri D; Panageas KS; Hummer A; Cranor M; Van Zee KJ; Hudis CA; Norton L; Borgen PI; Tan LK
    Cancer; 2004 Dec; 101(11):2509-15. PubMed ID: 15495180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients.
    Cheng SH; Horng CF; Clarke JL; Tsou MH; Tsai SY; Chen CM; Jian JJ; Liu MC; West M; Huang AT; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1401-9. PubMed ID: 16472935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J; Polgár C; Németh G
    Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell kinetic analysis of human breast carcinomas.
    Meyer JS
    Monogr Pathol; 1984; (25):45-58. PubMed ID: 6377051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
    Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.